8-K: Dyadic International Faces Nasdaq Delisting Threat Over Low Market Value

Dyadic International, Inc. has received a deficiency notice from Nasdaq for failing to maintain the minimum $35 million Market Value of Listed Securities, initiating a 180-day compliance period.

Summary

• Dyadic International, Inc. (DYAI) received a deficiency notice from The Nasdaq Stock Market LLC on June 23, 2025.
• The notice indicates that the company's securities have not maintained the minimum Market Value of Listed Securities (MVLS) of $35 million for the last 30 consecutive business days, violating Nasdaq Listing Rule 5550(b)(2).
• This notice does not immediately affect the listing of Dyadic's common stock on the Nasdaq Capital Market.
• The company has 180 calendar days, until December 20, 2025, to regain compliance.
• To regain compliance, Dyadic's MVLS must close at $35 million or more for a minimum of 10 consecutive business days before the Compliance Date.
• Failure to regain compliance by the deadline could lead to a delisting notification, which the company may appeal, though success is not assured.
• Dyadic intends to actively monitor its MVLS and evaluate options to resolve the deficiency and regain compliance.

Sentiment

Score: 2

Explanation: The document reports a significant negative event: a Nasdaq deficiency notice that could lead to delisting, indicating a severe challenge to the company's market standing and investor confidence.

Negatives

• The company received a deficiency notice from Nasdaq for failing to meet the minimum Market Value of Listed Securities (MVLS) requirement of $35 million.
• Failure to regain compliance by December 20, 2025, could result in the delisting of the company's common stock from Nasdaq.
• There is no assurance that an appeal against a delisting determination would be successful.

Risks

• The company has a history of net losses.
• There is a risk regarding the company's ability to maintain compliance with other Nasdaq continued listing standards and rules, including the minimum $1 bid price rule.
• The company faces capital needs.
• Market and regulatory acceptance of the company's microbial protein production platforms and other technologies is uncertain.
• There is a risk of failure to commercialize the company's microbial protein production platforms or other technologies.
• The company faces competition, including from alternative technologies.
• Results of nonclinical studies and clinical trials may not be favorable.
• Changes in global economic and financial conditions could negatively impact the company.
• The company's reliance on information technology poses risks.
• Dependence on third parties could affect operations.
• Government regulations and environmental, social, and governance (ESG) issues may impact the business.
• Intellectual property risks are present.

Future Outlook

Dyadic International, Inc. intends to actively monitor the Market Value of Listed Securities (MVLS) of its common stock and evaluate available options to resolve the deficiency and regain compliance with Nasdaq's minimum MVLS requirement by the December 20, 2025 deadline.

Management Comments

• The Company intends to actively monitor the MVLS of its common stock between now and the Compliance Date.
• As appropriate, the Company plans to evaluate available options to resolve the deficiency and regain compliance with the minimum MVLS requirement.

Industry Context

This announcement pertains to a specific company's compliance with stock exchange listing standards rather than broader industry trends. While other companies in the biotechnology sector may also face challenges in maintaining market capitalization, this notice is specific to Dyadic International's current valuation and does not reflect a systemic issue across the industry.

Stakeholder Impact

• Shareholders face increased risk of their investment being delisted from Nasdaq, potentially impacting liquidity and share price.
• Employees may face uncertainty regarding the company's future listing status and financial stability.
• The company's ability to attract future capital or partnerships could be negatively affected by the delisting threat.

Next Steps

• Dyadic International, Inc. must regain compliance with Nasdaq's minimum MVLS requirement by having its MVLS close at $35 million or more for a minimum of 10 consecutive business days.
• The company has until December 20, 2025, to achieve compliance.
• The company plans to actively monitor its MVLS and evaluate options to resolve the deficiency.

Key Dates

Recommendation

Keywords

Dyadic International, DYAI, Nasdaq, Delisting, Market Value of Listed Securities, MVLS, Listing Rule 5550(b)(2), Compliance, Biotechnology, Microbial Protein Production